What is the Share Price of ERIS Lifesciences Ltd?

ERIS Lifesciences Ltd share price is ₹1,330 As on 03 October, 2024|17:19

Home
>
Stocks
>
ERIS Lifesciences Ltd

ERIS Lifesciences Ltd

Q: What is the Market Cap of ERIS Lifesciences Ltd?

The Market Cap of ERIS Lifesciences Ltd is ₹18,024 As on 03 October, 2024|17:19

Q: What is PE Ratio of ERIS Lifesciences Ltd?

The P/E ratio of ERIS Lifesciences Ltd is 47.7 As on 03 October, 2024|17:19

Q: What is PB Ratio of ERIS Lifesciences Ltd?

The PB ratio of ERIS Lifesciences Ltd is 7.00 As on 03 October, 2024|17:19

₹ 1,330 +5.75 (0.43%)
Updated on 03-10-2024 4:45 PM

Stock Rating

Pros 2

Cons 5

Price Performance

Day's Low
₹1,310

Day's High
₹1,389

₹ 1,330

52-w low
₹804

52-w high
₹1,522.05

1,330

Day's open
₹1,326
Previous close
₹1,324.25
VWAP
₹1,351.74
Lower price band
₹1,059.40
Upper price band
₹1,589.10

Today's Market Action

The last traded share price of ERIS Lifesciences Ltd was 1,330 up by 0.43% on the NSE. Its last traded stock price on BSE was 1,329.25 up by 0.47%. The total volume of shares on NSE and BSE combined was 3,187,701 shares. Its total combined turnover was Rs 430.88 crores.

Medium and Long Term Market Action

ERIS Lifesciences Ltd hit a 52-week high of 1,522.05 on 06-09-2024 and a 52-week low of 804 on 26-10-2023. The stock price of ERIS Lifesciences Ltd is down by -8% over the last one month. It is up by 52.72% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

Market Cap (Cr): 18024
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About

Data not available.

FAQ's

What is Share Price of ERIS Lifesciences Ltd?

What is the Market Cap of ERIS Lifesciences Ltd?

What is PE Ratio of ERIS Lifesciences Ltd?

What is PB Ratio of ERIS Lifesciences Ltd?

What is the CAGR of ERIS Lifesciences Ltd?

How to Buy ERIS Lifesciences Ltd Share?

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

Momentum Strength
The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
Above Average Sustainable RoE
The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.

Cons

Low Interest Coverage
The company has a very low Interest coverage ratio of 7.96 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.43. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 120 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
High Promoter Pledge
The company has a relatively high promoter pledge to the extent of 19% of the total company's shareholding which can have a significantly negative impact on stock.
Negative Margin of Safety
The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(03/10/2024)

Margin of Safety Index: Moderate

0% People are bullish about ERIS Lifesciences Ltd

0 % People are bearish about ERIS Lifesciences Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %